The Most Important Hearing In Washington This Week – For Some Of Us, At Least
Impeachment? That’s nothing compared to the chance to hear publicly from Stephen Hahn about what kind of US FDA Commissioner he might be.
You may also be interested in...
US FDA commissioner nominee Stephen Hahn does not offer much detail on his policy positions; Senate confirmation could be completed by the end of the year.
Stephen Hahn will go before the Senate health committee less than three weeks after being nominated. Pink Sheet's historical charts illustrate how a long wait and a quick hearing could mean a rapid confirmation.
FDA is formally asking Congress to weigh in on the best approach to regulate CBD in consumer products. That provides another target for legislative attention that may mean that FDA’s core drug regulatory activities stay comfortably out of the spotlight.